Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Hemodynamic characterization of geometric cerebral aneurysm templates.

Nair P, Chong BW, Indahlastari A, Lindsay J, DeJeu D, Parthasarathy V, Ryan J, Babiker H, Workman C, Gonzalez LF, Frakes D.

J Biomech. 2015 Nov 28. pii: S0021-9290(15)00676-4. doi: 10.1016/j.jbiomech.2015.11.034. [Epub ahead of print]

PMID:
26654674
2.

Hemodynamic Characterization of Geometric Cerebral Aneurysm Templates Treated With Embolic Coils.

Nair P, Chong BW, Indahlastari A, Ryan J, Workman C, Haithem Babiker M, Yadollahi Farsani H, Baccin CE, Frakes D.

J Biomech Eng. 2016 Feb 1;138(2). doi: 10.1115/1.4032046.

PMID:
26593324
3.

Negative emotions towards others are diminished in remitted major depression.

Zahn R, Lythe KE, Gethin JA, Green S, Deakin JF, Workman C, Moll J.

Eur Psychiatry. 2015 Jun;30(4):448-53. doi: 10.1016/j.eurpsy.2015.02.005. Epub 2015 Mar 6.

PMID:
25752724
4.

Pheochromocytoma supporting blood pressure in the setting of cardiogenic shock.

Ditkofsky N, Workman C.

Clin Imaging. 2015 Jan-Feb;39(1):136-9. doi: 10.1016/j.clinimag.2014.09.012. Epub 2014 Oct 16.

PMID:
25457540
5.

Post-metabolic response to passive normobaric hypoxic exposure in sedendary overweight males: a pilot study.

Workman C, Basset FA.

Nutr Metab (Lond). 2012 Nov 16;9(1):103. doi: 10.1186/1743-7075-9-103.

6.

Week 96 efficacy, virology and safety of darunavir/r versus lopinavir/r in treatment-experienced patients in TITAN.

Bánhegyi D, Katlama C, da Cunha CA, Schneider S, Rachlis A, Workman C, De Meyer S, Vandevoorde A, Van De Casteele T, Tomaka F.

Curr HIV Res. 2012 Mar;10(2):171-81.

PMID:
22339125
7.

Alterations in immune function are associated with liver enzyme elevation in HIV and HCV co-infection after commencement of combination antiretroviral therapy.

Cameron BA, Emerson CR, Workman C, Kelly MD, Lloyd AR, Post JJ.

J Clin Immunol. 2011 Dec;31(6):1079-83. doi: 10.1007/s10875-011-9587-6. Epub 2011 Sep 20.

PMID:
21932111
8.

Revealing the beneficial effect of protease supplementation to high gravity beer fermentations using "-omics" techniques.

Piddocke MP, Fazio A, Vongsangnak W, Wong ML, Heldt-Hansen HP, Workman C, Nielsen J, Olsson L.

Microb Cell Fact. 2011 Apr 23;10:27. doi: 10.1186/1475-2859-10-27.

9.

Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients.

Cahn P, Fourie J, Grinsztejn B, Hodder S, Molina JM, Ruxrungtham K, Workman C, Van De Casteele T, De Doncker P, Lathouwers E, Tomaka F.

AIDS. 2011 Apr 24;25(7):929-39. doi: 10.1097/QAD.0b013e328345ee95.

PMID:
21346512
10.

Reducing high-risk drinking in mandated college students: evaluation of two personalized normative feedback interventions.

Doumas DM, Workman C, Smith D, Navarro A.

J Subst Abuse Treat. 2011 Jun;40(4):376-85. doi: 10.1016/j.jsat.2010.12.006. Epub 2011 Feb 4.

PMID:
21295938
11.

Differential subcellular localization of the regulatory T-cell protein LAG-3 and the coreceptor CD4.

Woo SR, Li N, Bruno TC, Forbes K, Brown S, Workman C, Drake CG, Vignali DA.

Eur J Immunol. 2010 Jun;40(6):1768-77. doi: 10.1002/eji.200939874.

12.

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials.

Eron JJ, Young B, Cooper DA, Youle M, Dejesus E, Andrade-Villanueva J, Workman C, Zajdenverg R, Fätkenheuer G, Berger DS, Kumar PN, Rodgers AJ, Shaughnessy MA, Walker ML, Barnard RJ, Miller MD, Dinubile MJ, Nguyen BY, Leavitt R, Xu X, Sklar P; SWITCHMRK 1 and 2 investigators.

Lancet. 2010 Jan 30;375(9712):396-407. doi: 10.1016/S0140-6736(09)62041-9. Epub 2010 Jan 12.

PMID:
20074791
13.

Diet of the Delacour's langur (Trachypithecus delacouri) in Van Long Nature Reserve, Vietnam.

Workman C.

Am J Primatol. 2010 Apr;72(4):317-24. doi: 10.1002/ajp.20785.

PMID:
20027639
14.
15.

Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis.

Mills AM, Nelson M, Jayaweera D, Ruxrungtham K, Cassetti I, Girard PM, Workman C, Dierynck I, Sekar V, Abeele CV, Lavreys L.

AIDS. 2009 Aug 24;23(13):1679-88. doi: 10.1097/QAD.0b013e32832d7350.

PMID:
19487905
16.

A delayed hypersensitivity reaction to enfuvirtide after rechallenge.

Emerson CR, Post JJ, Workman C.

Int J STD AIDS. 2009 Apr;20(4):288-9. doi: 10.1258/ijsa.2008.008331.

PMID:
19304981
17.

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.

Mitsuyasu RT, Merigan TC, Carr A, Zack JA, Winters MA, Workman C, Bloch M, Lalezari J, Becker S, Thornton L, Akil B, Khanlou H, Finlayson R, McFarlane R, Smith DE, Garsia R, Ma D, Law M, Murray JM, von Kalle C, Ely JA, Patino SM, Knop AE, Wong P, Todd AV, Haughton M, Fuery C, Macpherson JL, Symonds GP, Evans LA, Pond SM, Cooper DA.

Nat Med. 2009 Mar;15(3):285-92. doi: 10.1038/nm.1932. Epub 2009 Feb 15.

18.

Effects of boosted tipranavir and lopinavir on body composition, insulin sensitivity and adipocytokines in antiretroviral-naive adults.

Carr A, Ritzhaupt A, Zhang W, Zajdenverg R, Workman C, Gatell JM, Cahn P, Chaves R.

AIDS. 2008 Nov 12;22(17):2313-21. doi: 10.1097/QAD.0b013e328315a7a5.

PMID:
18981770
19.

Single- and multiple-dose pharmacokinetics of etravirine administered as two different formulations in HIV-1-infected patients.

Kakuda TN, Schöller-Gyüre M, Workman C, Arasteh K, Pozniak AL, De Smedt G, Beets G, Peeters M, Vandermeulen K, Woodfall BJ, Hoetelmans RM.

Antivir Ther. 2008;13(5):655-61.

PMID:
18771049
20.

Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II.

Liang B, Workman C, Lee J, Chew C, Dale BM, Colonna L, Flores M, Li N, Schweighoffer E, Greenberg S, Tybulewicz V, Vignali D, Clynes R.

J Immunol. 2008 May 1;180(9):5916-26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk